Can anesthetic treatment worsen outcome in status epilepticus?

Epilepsy and Behavior

Volumn 49, Issue , 2015, Pages 294-297

  Sutter, Raoul ^a   Kaplan, Peter W ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Anesthetic drugs; Neurocritical care; Outcome; Status epilepticus; Therapeutic coma

Indexed keywords

ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; HYPERTENSIVE FACTOR; ISOFLURANE; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PROPOFOL; THIOPENTAL; ANTICONVULSIVE AGENT;

BRAIN INJURY; CARDIOTOXICITY; COMA; DISEASE ASSOCIATION; DISEASE DURATION; DRUG FATALITY; EPILEPTIC STATE; HEART FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPOTENSION; INFECTION; INTENSIVE CARE UNIT; LIVER TOXICITY; METABOLIC ACIDOSIS; NONHUMAN; PRACTICE GUIDELINE; PROPOFOL INFUSION SYNDROME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; REVIEW; RHABDOMYOLYSIS; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VENTILATOR ASSOCIATED PNEUMONIA; COMPLICATION; INTENSIVE CARE; STATUS EPILEPTICUS;

ANESTHETICS; ANTICONVULSANTS; CRITICAL CARE; HUMANS; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 84938991632     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.02.044     Document Type: Article

References (42)

1. Novy J., Logroscino G., Rossetti A.O. Refractory status epilepticus: a prospective observational study. Epilepsia 2010, 51(2):251-256.
2. Holtkamp M., Masuhr F., Harms L., Einhaupl K.M., Meierkord H., Buchheim K. The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists. J Neurol Neurosurg Psychiatry 2003, 74(8):1095-1099.
3. Kaplan P.W. Nonconvulsive status epilepticus. Neurology 2003, 61(8):1035-1036.
4. Parviainen I., Kalviainen R., Ruokonen E. Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons. Neurol Res 2007, 29(7):667-671.
5. Brophy G.M., Bell R., Claassen J., et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012, 17(1):3-23.
6. Meierkord H., Boon P., Engelsen B., et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010, 17(3):348-355.
7. Kowalski R.G., Ziai W.C., Rees R.N., et al. Third-line antiepileptic therapy and outcome in status epilepticus: The impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012, 40(9):2677-2684.
8. Sutter R., Marsch S., Fuhr P., Kaplan P.W., Rüegg S. Anesthetic drugs in status epilepticus - risk or rescue? A six-year cohort study. Neurology 2013, 82(8):656-664.
9. Marchi N.A., Novy J., Faouzi M., Stähli C., Burnand B., Rossetti A.O. Status epilepticus: impact of therapeutic coma on outcome. Crit Care Med 2015.
10. Guo D., Arnspiger S., Rensing N.R., Wong M. Brief seizures cause dendritic injury. Neurobiol Dis 2012, 45(1):348-355.
11. Kawaguchi K., Hickey R.W., Rose M.E., Zhu L., Chen J., Graham S.H. Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus. Brain Res 2005, 1050(1-2):130-137.
12. Tanaka K., Lowry T., Simon R.P. Bilateral intranigral NMDA blockade increases status duration and neuronal injury from systemic kainic acid. Brain Res 1994, 660(2):192-198.
13. Brierley J.B., Horton R.W., Meldrum B.S. Physiological observations during prolonged epileptic seizures in primates and their relation to subsequent brain damage. J Physiol 1972, 222(1):69P-70P.
14. Meldrum B.S., Brierley J.B. Neuronal loss and gliosis in the hippocampus following repetitive epileptic seizures induced in adolescent baboons by allylglycine. Brain Res 1972, 48:361-365.
15. Sutter R., Kaplan P.W., Rüegg S. Outcome predictors for status epilepticus-what really counts. Nat Rev Neurol 2013, 9(9):525-534.
16. Corsellis J.A., Bruton C.J. Neuropathology of status epilepticus in humans. Adv Neurol 1983, 34:129-139.
17. Salmenpera T., Kalviainen R., Partanen K., Mervaala E., Pitkanen A. MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus. Epilepsy Res 2000, 40(2-3):155-170.
18. Drislane F.W., Blum A.S., Lopez M.R., Gautam S., Schomer D.L. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours. Epilepsia 2009, 50(6):1566-1571.
19. Towne A.R. Epidemiology and outcomes of status epilepticus in the elderly. Int Rev Neurobiol 2007, 81:111-127.
20. Sutter R., Marsch S., Fuhr P., Rüegg S. Mortality and recovery from refractory status epilepticus in the ICU: a 7-year observational study. Epilepsia 2013, 54(3):502-511.
21. Sagduyu A., Tarlaci S., Sirin H. Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality. J Neurol 1998, 245(10):640-646.
22. Towne A.R., Pellock J.M., Ko D., DeLorenzo R.J.. Determinants of mortality in status epilepticus. Epilepsia 1994, 35(1):27-34.
23. Logroscino G., Hesdorffer D.C., Cascino G.D., Annegers J.F., Bagiella E., Hauser WA. Long-term mortality after a first episode of status epilepticus. Neurology 2002, 58(4):537-541.
24. Wu Y.W., Shek D.W., Garcia P.A., Zhao S., Johnston S.C. Incidence and mortality of generalized convulsive status epilepticus in California. Neurology 2002, 58(7):1070-1076.
25. Waterhouse E.J., Garnett L.K., Towne A.R., et al. Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia. Epilepsia 1999, 40(6):752-758.
26. Chin R.F., Neville B.G., Scott R.C. A systematic review of the epidemiology of status epilepticus. Eur J Neurol 2004, 11(12):800-810.
27. Rossetti A.O., Logroscino G., Bromfield EB.. A clinical score for prognosis of status epilepticus in adults. Neurology 2006, 66(11):1736-1738.
28. Hocker S.E., Shorvon S. Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. Neurology 2014, 83(9):866.
29. Rossetti A.O., Alvarez V., Januel J.M., Burnand B. Treatment deviating from guidelines does not influence status epilepticus prognosis. J Neurol 2013, 260(2):421-428.
30. Etsten B., Li T.H. Hemodynamic changes during thiopental anesthesia in humans: cardiac output, stroke volume, total peripheral resistance, and intrathoracic blood volume. J Clin Invest 1955, 34(3):500-510.
31. Iyer V.N., Hoel R., Rabinstein A.A. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med 2009, 37(12):3024-3030.
32. Claassen J., Hirsch L.J., Emerson R.G., Mayer S.A. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia 2002, 43(2):146-153.
33. Rossetti A.O., Logroscino G., Bromfield E.B. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol 2005, 62(11):1698-1703.
34. Sutter R., Tschudin-Sutter S., Grize L., et al. Associations between infections and clinical outcome parameters in status epilepticus: a retrospective 5-year cohort study. Epilepsia 2012, 53(9):1489-1497.
35. Prabhakar H., Bindra A., Singh G.P., Kalaivani M., et al. Propofol versus thiopental sodium for the treatment of refractory status epilepticus. Cochrane Database Syst Rev 2012, 8:CD009202.
36. Steriade M., Amzica F., Contreras D. Cortical and thalamic cellular correlates of electroencephalographic burst-suppression. Electroencephalogr Clin Neurophysiol 1994, 90(1):1-16.
37. Amzica F., Kroeger D. Cellular mechanisms underlying EEG waveforms during coma. Epilepsia 2011, 52(Suppl. 8):25-27.
38. Buzsaki G. Two-stage model of memory trace formation: a role for "noisy" brain states. Neuroscience 1989, 31(3):551-570.
39. Kroeger D., Amzica F. Hypersensitivity of the anesthesia-induced comatose brain. J Neurosci 2007, 27(39):10597-10607.
40. Jordan K.G., Hirsch L.J. In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con. Epilepsia 2006, 47(Suppl. 1):41-45.
41. Sutter R. Conflicting clinical implications of therapeutic coma for status epilepticus. Crit Care Med 2015.
42. Sutter R., Kaplan P.W., Rüegg S. Independent external validation of the Status Epilepticus Severity Score. Crit Care Med 2013, 41:e475-e479.